Phamatech, Incorporated

Phamatech, Incorporated, doing business as Phamatech Laboratories and Diagnostics, is a San Diego-based minority-owned, self-certified small disadvantaged business and Asian-Pacific American-owned manufacturer that supplies urinalysis testing cups, laboratory confirmation services, and related diagnostic products to the federal correctional system as a prime contractor under the total small business set-aside. The company operates almost exclusively through a single $6.26 million Blanket Purchase Agreement with the Bureau of Prisons Central Office awarded March 1, 2024, extending through September 30, 2026, with 100% of recent awards deriving from prime contracting positions (5,332 awards) rather than subcontracting.

Phamatech's federal footprint is concentrated within the Department of Justice Bureau of Prisons network. The top customers by award count—Federal Correctional Institution Elkton, Federal Correctional Institution Three Rivers, Federal Correctional Complex Allenwood, United States Penitentiary Big Sandy, and Federal Transfer Center Oklahoma City—account for approximately 13% of all awards. By dollar value, the top five customers are Federal Correctional Complex Coleman (58 awards, $679 thousand), Federal Correctional Complex Allenwood (103 awards, $404 thousand), Federal Correctional Complex Beaumont (48 awards, $377 thousand), Federal Correctional Complex Petersburg (74 awards, $219 thousand), and Federal Correctional Institution Herlong (71 awards, $184 thousand). The concentration is narrow: 111 distinct customer agencies are served, but the vast majority of volume and value flow through Bureau of Prisons facilities. Representative work includes quarterly and annual BPA calls for 14-panel urinalysis test cups, chain of custody forms, and laboratory confirmation testing services at individual correctional institutions across the system, with individual call values typically ranging from several hundred to over $20,000 on a firm fixed-price basis.

The company's vehicle position is dominated by the Bureau of Prisons master BPA, which anchors task orders placed under the General Services Administration Multiple Award Schedule (5,225 task orders, $26 million combined potential value). Phamatech also carries a $2 million General Services Administration Federal Supply Schedule contract (FSS Contract #47QSMS24D001K), though this vehicle serves as a secondary mechanism with limited independent activity. A secondary Indefinite Delivery Contract (N0018912DZ025) carries $652 thousand combined potential value across seven task orders, and references to a Law Enforcement & Security Services vehicle appear in the source, though the relationship to core urinalysis business is unclear.

Activity has grown measurably. Awards per year increased from 75 in 2022 to 177 in 2025, though 2026 shows 91 awards year-to-date as of the source snapshot. The combined potential value across all awards stands at $54.3 million, with $18.2 million (34%) obligated. Within the next twenty-four months, 75 awards carrying $619 thousand combined potential value reach ultimate completion, representing moderate recompete exposure tied to routine quarterly and annual procurement cycles within the Bureau of Prisons.

Phamatech's NAICS and PSC concentration reflects its narrow specialization: Analytical Laboratory Instrument Manufacturing dominates (4,853 awards), followed by Pharmaceutical Preparation Manufacturing (311 awards). PSC codes align closely: Replenishable Field Medical Sets, Kits, and Outfits (2,409 awards) and Reference Laboratory Testing (1,636 awards) comprise the bulk. The company manufactures rapid diagnostic devices and delivers laboratory testing services; its federal presence is entirely tied to inmate drug screening, health monitoring, and urinalysis surveillance within correctional facilities.

Phamatech competes entirely under set-asides. All awards in the source carry either the Total Small Business set-aside or no set-aside designation at the task-order level, but the underlying master BPA is reserved for total small business, and the company's SBA designations (minority-owned, small disadvantaged business, Asian-Pacific American owned) are core to its market positioning. The vendor does not pursue or hold full-and-open federal contracts; its entire federal footprint depends on access to the Bureau of Prisons BPA and GSA schedule vehicles reserved for or preferenced toward small business.

The company has no visible subcontracting footprint (1 sub award out of 5,333 total, a Louisiana Department of Health grant sub-award for OTC COVID test kits in 2023). Phamatech operates as a prime supplier on all substantive Bureau of Prisons work and does not appear in source data as a subcontractor to larger defense or federal IT primes. Its federal customer base is exclusively civilian (Bureau of Prisons, Department of Veterans Affairs, and isolated GSA orders), with no DoD prime awards or subcontract engagement evident.

Phamatech, Inc. is a global manufacturer of rapid diagnostic devices and a provider of laboratory testing for medication monitoring, illicit drugs, alcohol, and pharmacogenetic testing. We utilize state-of-the-art technology and equipment in our manufacturing process and in our laboratory. We are the only laboratory that manufactures its own on-site testing products in the United States, and that confirms results at the highest certification levels.